Year
int64
2.02k
2.03k
UI
stringlengths
7
10
UPDATED_FIELD
stringclasses
13 values
REPLACED_VALUE
stringlengths
1
912
REPLACEMENT_VALUE
stringlengths
1
910
NOTES
stringclasses
19 values
2,023
C010423
SO
Toxicol Appl Pharmacol 36(2):255;1976
J Neuropathol Exp Neurol 38(5):532;1979
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 36(2):255;1976
Toxicol Appl Pharmacol 1979;50(1):171
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 36(2):255;1976
Toxicol Appl Pharmacol 31(3):430;1975
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 36(2):255;1976
Toxicol Appl Pharmacol 43:373;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 36(2):255;1976
Toxicol Appl Pharmacol 43:425;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 36(2):255;1976
Toxicol Appl Pharmacol 45(3):771;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Brain Res 1980;186(2):343
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Contact Dermatitis 1979;5(4):276
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Food Cosmet Toxicol 16(6):553;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
J Neuropathol Exp Neurol 38(5):532;1979
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Toxicol Appl Pharmacol 1979;50(1):171
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Toxicol Appl Pharmacol 31(3):430;1975
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Toxicol Appl Pharmacol 36(2):255;1976
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Toxicol Appl Pharmacol 43:425;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:373;1978
Toxicol Appl Pharmacol 45(3):771;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Brain Res 1980;186(2):343
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Contact Dermatitis 1979;5(4):276
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Food Cosmet Toxicol 16(6):553;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
J Neuropathol Exp Neurol 38(5):532;1979
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Toxicol Appl Pharmacol 1979;50(1):171
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Toxicol Appl Pharmacol 31(3):430;1975
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Toxicol Appl Pharmacol 36(2):255;1976
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Toxicol Appl Pharmacol 43:373;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 43:425;1978
Toxicol Appl Pharmacol 45(3):771;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Brain Res 1980;186(2):343
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Contact Dermatitis 1979;5(4):276
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Food Cosmet Toxicol 16(6):553;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
J Neuropathol Exp Neurol 38(5):532;1979
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Toxicol Appl Pharmacol 1979;50(1):171
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Toxicol Appl Pharmacol 31(3):430;1975
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Toxicol Appl Pharmacol 36(2):255;1976
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Toxicol Appl Pharmacol 43:373;1978
Source updated on a SCR
2,023
C010423
SO
Toxicol Appl Pharmacol 45(3):771;1978
Toxicol Appl Pharmacol 43:425;1978
Source updated on a SCR
2,023
C010423
SY
de-squaman
De-squaman
Synonym updated on an scr
2,023
C010946
SO
Khirurgiia (Sofiia) 31(3):185;1978
Praxis 64(19):592;1975
Source updated on a SCR
2,023
C010946
SO
Praxis 64(19):592;1975
Khirurgiia (Sofiia) 31(3):185;1978
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 33(1):21;1975
Toxicol Appl Pharmacol 35(1):21;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 33(1):21;1975
Toxicol Appl Pharmacol 37(2):363;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 33(1):21;1975
Toxicol Appl Pharmacol 37(3):445;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 35(1):21;1976
Toxicol Appl Pharmacol 33(1):21;1975
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 35(1):21;1976
Toxicol Appl Pharmacol 37(2):363;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 35(1):21;1976
Toxicol Appl Pharmacol 37(3):445;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 37(2):363;1976
Toxicol Appl Pharmacol 33(1):21;1975
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 37(2):363;1976
Toxicol Appl Pharmacol 35(1):21;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 37(2):363;1976
Toxicol Appl Pharmacol 37(3):445;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 37(3):445;1976
Toxicol Appl Pharmacol 33(1):21;1975
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 37(3):445;1976
Toxicol Appl Pharmacol 35(1):21;1976
Source updated on a SCR
2,023
C011058
SO
Toxicol Appl Pharmacol 37(3):445;1976
Toxicol Appl Pharmacol 37(2):363;1976
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 2:4;1978
Gig Tr Prof Zabol 7:57;1978
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 2:4;1978
Gig Tr Prof Zabol 9:36;1974
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 2:4;1978
Sov Med 1979;(11):107
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 7:57;1978
Gig Tr Prof Zabol 2:4;1978
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 7:57;1978
Gig Tr Prof Zabol 9:36;1974
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 7:57;1978
Sov Med 1979;(11):107
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 9:36;1974
Gig Tr Prof Zabol 2:4;1978
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 9:36;1974
Gig Tr Prof Zabol 7:57;1978
Source updated on a SCR
2,023
C011107
SO
Gig Tr Prof Zabol 9:36;1974
Sov Med 1979;(11):107
Source updated on a SCR
2,023
C011107
SO
Sov Med 1979;(11):107
Gig Tr Prof Zabol 2:4;1978
Source updated on a SCR
2,023
C011107
SO
Sov Med 1979;(11):107
Gig Tr Prof Zabol 7:57;1978
Source updated on a SCR
2,023
C011107
SO
Sov Med 1979;(11):107
Gig Tr Prof Zabol 9:36;1974
Source updated on a SCR
2,023
C011396
SO
Biochem Biophys Res Comm 67(1):272;1975
Boll Soc Ital Biol Speriment 52(11):812;1976
Source updated on a SCR
2,023
C011396
SO
Biochem Biophys Res Comm 67(1):272;1975
Life Sci 23(14):1423;1978
Source updated on a SCR
2,023
C011396
SO
Boll Soc Ital Biol Speriment 52(11):812;1976
Biochem Biophys Res Comm 67(1):272;1975
Source updated on a SCR
2,023
C011396
SO
Boll Soc Ital Biol Speriment 52(11):812;1976
Life Sci 23(14):1423;1978
Source updated on a SCR
2,023
C011396
SO
Life Sci 23(14):1423;1978
Biochem Biophys Res Comm 67(1):272;1975
Source updated on a SCR
2,023
C011396
SO
Life Sci 23(14):1423;1978
Boll Soc Ital Biol Speriment 52(11):812;1976
Source updated on a SCR
2,023
C011711
NO
a lysophospholipase expressed in eosinophils and basophils; It hydrolyzes lysophosphatidylcholine to glycerophosphocholine and a free fatty acid; It is both structurally and functionally related to the galectin family of beta-galactoside binding proteins; RefSeq NM_001828 (human)
a lysophospholipase expressed in eosinophils and basophils; It hydrolyzes lysophosphatidylcholine to glycerophosphocholine and a free fatty acid; It is both structurally and functionally related to the galectin family of beta-galactoside binding proteins
Note updated on a SCR
2,023
C011867
SO
Can J Microbiol 22(3):384;1976
Experientia 33(8):988;1977
Source updated on a SCR
2,023
C011867
SO
Experientia 33(8):988;1977
Can J Microbiol 22(3):384;1976
Source updated on a SCR
2,023
C012293
NO
antiallergic drug; potent inhibitor of homologous passive cutaneous anaphylaxis; structure
antiallergic drug; potent inhibitor of homologous passive cutaneous anaphylaxis
Note updated on a SCR
2,023
C012293
SO
Allergy 1979;34(4):213
Br J Pharmacol 58(4):483;1976
Source updated on a SCR
2,023
C012293
SO
Allergy 1979;34(4):213
J Allergy Clin Immunol 57(5):396;1976
Source updated on a SCR
2,023
C012293
SO
Allergy 1979;34(4):213
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Source updated on a SCR
2,023
C012293
SO
Allergy 1979;34(4):213
Nippon Yakurigaku Zasshi 74(6):699;1978
Source updated on a SCR
2,023
C012293
SO
Br J Pharmacol 58(4):483;1976
Allergy 1979;34(4):213
Source updated on a SCR
2,023
C012293
SO
Br J Pharmacol 58(4):483;1976
J Allergy Clin Immunol 57(5):396;1976
Source updated on a SCR
2,023
C012293
SO
Br J Pharmacol 58(4):483;1976
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Source updated on a SCR
2,023
C012293
SO
Br J Pharmacol 58(4):483;1976
Nippon Yakurigaku Zasshi 74(6):699;1978
Source updated on a SCR
2,023
C012293
SO
J Allergy Clin Immunol 57(5):396;1976
Allergy 1979;34(4):213
Source updated on a SCR
2,023
C012293
SO
J Allergy Clin Immunol 57(5):396;1976
Br J Pharmacol 58(4):483;1976
Source updated on a SCR
2,023
C012293
SO
J Allergy Clin Immunol 57(5):396;1976
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Source updated on a SCR
2,023
C012293
SO
J Allergy Clin Immunol 57(5):396;1976
Nippon Yakurigaku Zasshi 74(6):699;1978
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Allergy 1979;34(4):213
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Br J Pharmacol 58(4):483;1976
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(4):467-483;1978
J Allergy Clin Immunol 57(5):396;1976
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Nippon Yakurigaku Zasshi 74(6):699;1978
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(6):699;1978
Allergy 1979;34(4):213
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(6):699;1978
Br J Pharmacol 58(4):483;1976
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(6):699;1978
J Allergy Clin Immunol 57(5):396;1976
Source updated on a SCR
2,023
C012293
SO
Nippon Yakurigaku Zasshi 74(6):699;1978
Nippon Yakurigaku Zasshi 74(4):467-483;1978
Source updated on a SCR
2,023
C012526
SO
Biull Eksp Biol Med 81(5):899;1976
Invest Ophthalmol Vis Sci 18(3):237;1979
Source updated on a SCR
2,023
C012526
SO
Biull Eksp Biol Med 81(5):899;1976
Pharmacol Res Commun 10(2):133;1978
Source updated on a SCR
2,023
C012526
SO
Invest Ophthalmol Vis Sci 18(3):237;1979
Biull Eksp Biol Med 81(5):899;1976
Source updated on a SCR
2,023
C012526
SO
Invest Ophthalmol Vis Sci 18(3):237;1979
Pharmacol Res Commun 10(2):133;1978
Source updated on a SCR
2,023
C012526
SO
Pharmacol Res Commun 10(2):133;1978
Biull Eksp Biol Med 81(5):899;1976
Source updated on a SCR
2,023
C012526
SO
Pharmacol Res Commun 10(2):133;1978
Invest Ophthalmol Vis Sci 18(3):237;1979
Source updated on a SCR
2,023
C014024
SO
Acta Pharmacol Toxicol 41:11;1977
Chem Biol Interact 15(4):365;1976
Source updated on a SCR
2,023
C014024
SO
Acta Pharmacol Toxicol 41:11;1977
Chem Biol Interact 27(1):99;1979
Source updated on a SCR
2,023
C014024
SO
Acta Pharmacol Toxicol 41:11;1977
Comp Biochem Physiol 60C(2):193;1978
Source updated on a SCR
2,023
C014024
SO
Acta Pharmacol Toxicol 41:11;1977
Toxicol Appl Pharmacol 48(3):387;1979
Source updated on a SCR